Krizova P, Musilek M
National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic.
Cent Eur J Public Health. 1995 Nov;3(4):189-94.
Invasive meningococcal disease, caused mainly by Neisseria meningitidis B, occurred only sporadically in the Czech Republic for a long period, and the use of meningococcal polysaccharide vaccine was never indicated. This situation changed in 1993, when a new meningococcal clone appeared. By means of sero/subtyping (using Whole Cell ELISA) Neisseria meningitidis C:2a:P1.2(P1.5) was quickly revealed to be the causative agent of this unusual epidemiological situation. ET typing by multilocus enzyme electrophoresis showed the prevalence of the ET-15 electrophoretic type, which belongs to the ET-37 complex. This new clone had never been identified in the Czech Republic at least since 1973. The new clone caused an increase in the incidence of invasive meningococcal disease in the army campuses in the eastern part of the country and two local invasive meningococcal disease outbreaks in civilian population at the beginning of 1993. In May 1993, the highest age-specific incidence in the most affected district was found in the age group of 15-19 years (52.1 per 100,000), while the respective age specific incidence for the whole Czech Republic was 1.9 per 100,000. The vaccination campaign started in the most affected district at the beginning of June 1993 and was focused on the most affected age group, 15-19 years. After this targeted vaccination campaign the number of invasive meningococcal disease decreased in this district statistically significantly. The new clone Neisseria meningitidis C:2a:P1.2(P1.5) is causing not only a new epidemiological situation, but also a new clinical situation, characterized by more serious and frequently atypical courses of invasive meningococcal disease with a high incidence of Waterhouse-Friderichsen syndrome and meningococcal sepsis. A high fatality rate was found for the clone Neisseria meningitidis C:2a:P1.2(P1.5) (20%) compared to the "normal" fatality rate of the "non C" invasive meningococcal disease (8.8%) in 1993. The new clone Neisseria meningitidis C:2a:P1.2(P1.5) spread between 1993 and 1995 to the whole country, nevertheless, to date no similar epidemiological situation was identified, as was that in two districts in spring 1993. A more rapid increase in the age specific morbidity occurred recently in the age group of 1-4 years and in adult age groups as well.
侵袭性脑膜炎球菌病主要由B群脑膜炎奈瑟菌引起,在捷克共和国长期仅偶有发生,因此从未有过使用脑膜炎球菌多糖疫苗的指征。1993年情况发生了变化,出现了一种新的脑膜炎球菌克隆株。通过血清/亚型分型(使用全细胞酶联免疫吸附测定法),很快查明脑膜炎奈瑟菌C:2a:P1.2(P1.5)是这种异常流行病学情况的病原体。多位点酶电泳进行的ET分型显示ET-15电泳型占优势,该型属于ET-37复合体。至少自1973年以来,这种新克隆株在捷克共和国从未被发现过。这种新克隆株导致该国东部军营中侵袭性脑膜炎球菌病发病率上升,并在1993年初引发了两起平民局部侵袭性脑膜炎球菌病疫情。1993年5月,在受影响最严重的地区,年龄特异性发病率最高的是15至19岁年龄组(每10万人中52.1例),而整个捷克共和国相应的年龄特异性发病率为每10万人中1.9例。1993年6月初在受影响最严重的地区启动了疫苗接种运动,重点针对受影响最严重的15至19岁年龄组。在这次有针对性的疫苗接种运动之后,该地区侵袭性脑膜炎球菌病的病例数在统计学上显著减少。新克隆株脑膜炎奈瑟菌C:2a:P1.2(P1.5)不仅造成了新的流行病学情况,还导致了新的临床情况,其特征是侵袭性脑膜炎球菌病的病程更严重且常常不典型,华-弗综合征和脑膜炎球菌败血症的发病率很高。与1993年“非C群”侵袭性脑膜炎球菌病的“正常”死亡率(8.8%)相比,克隆株脑膜炎奈瑟菌C:2a:P1.2(P1.5)的死亡率很高(20%)。新克隆株脑膜炎奈瑟菌C:2a:P1.2(P1.5)在1993年至1995年间蔓延至全国,但迄今为止,尚未发现与1993年春季两个地区类似的流行病学情况。最近,1至4岁年龄组和成人年龄组的年龄特异性发病率上升得更快。